Back to Search
Start Over
New insights in efficacy of different enzyme replacement therapy dosages in Fabry disease: Switch studies data following agalsidase beta shortage.
- Source :
- Clinical Genetics; Mar2023, Vol. 103 Issue 3, p371-376, 6p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 00099163
- Volume :
- 103
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Clinical Genetics
- Publication Type :
- Academic Journal
- Accession number :
- 161618794
- Full Text :
- https://doi.org/10.1111/cge.14266